PMOS (Formerly PCOS), Hirsutism and Endometriosis for NEET PG OBG: Rotterdam Criteria, Tests, Long-term Risks, Treatment and Endometriosis Basics

Start Here

🎯 Exam priority: Very high. Expect: Rotterdam criteria, the ultrasound definition of polycystic ovaries, which tests exclude CAH, Cushing, tumours, hyperprolactinaemia and thyroid disease, why endometrial cancer risk rises, first-line treatment and ovulation induction, hirsutism vs virilisation, and endometriosis sites, triad and treatment.

CBME mapping: OG30. Note: MSD now calls PCOS polyendocrine metabolic ovarian syndrome (PMOS) — exams may use either name.

PMOS (formerly PCOS) definition, Rotterdam criteria, tests, risks and treatment; hirsutism; endometriosis sites, theories and treatment

PMOS criteria, tests, risks and treatment; endometriosis essentials. Drawn by TrackNation.

PMOS (Formerly PCOS): Diagnosis (MSD)

  • Affects 5–10% of women; the renaming stresses hormonal and metabolic risks (insulin resistance is thought to be the initial abnormality) rather than "cysts".

  • Rotterdam — any 2 of 3: oligo/anovulation; clinical or biochemical hyperandrogenism; polycystic ovaries = ≥12 follicles of 2–9 mm in each ovary and/or ovarian volume >10 ml on TVS (TVS is not done in adolescents).

  • Exclude mimics: pregnancy test, FSH, prolactin, TSH; early-morning 17-hydroxyprogesterone (non-classic CAH); cortisol (Cushing). Tumour clues: testosterone >150 ng/dl, DHEAS >800 mcg/dl (adrenal), or virilisation (clitoromegaly, deep voice, male-pattern baldness).

  • Features: irregular periods, hirsutism, acne, obesity, acanthosis nigricans (from high insulin), infertility.

PMOS: Risks and Treatment (MSD)

  • Long-term: unopposed oestrogen → endometrial hyperplasia and cancer; type 2 diabetes, impaired glucose tolerance, dyslipidaemia, hypertension, sleep apnoea, fatty liver, depression and anxiety.

  • Treatment: weight loss and exercise (can restore ovulation); combined pills or progestins to regulate cycles and protect the endometrium (antiandrogenic progestins: drospirenone, dienogest); metformin for insulin resistance.

  • Infertility: MSD's PMOS chapter lists clomiphene as first-line with letrozole as an option, while its ovulatory-dysfunction chapter says many clinicians now prefer letrozole (better in obese women) — know both.

  • Hirsutism: PMOS is the commonest cause; others — CAH, Cushing, adrenal/ovarian tumours, drugs. Antiandrogens (spironolactone 25–100 mg twice daily, finasteride) only with reliable contraception; plus hair removal methods.

Endometriosis (MSD)

  • Endometrial tissue outside the uterus — commonly ovaries, broad ligaments, posterior cul-de-sac, uterosacral ligaments, peritoneum; also caesarean scars, bowel, bladder, rarely lung/pleura.

  • Theories: retrograde menstruation (most accepted), coelomic metaplasia, Müllerian rests.

  • Triad: dysmenorrhoea, dyspareunia, infertility (± dysuria, dyschezia). Symptom severity does not match stage. Infertility: endometriomas destroy follicles (low reserve), adhesions, luteinised unruptured follicle, raised peritoneal prostaglandins and macrophage activity.

  • Diagnosis is often clinical (± TVS/MRI); laparoscopy (± biopsy) helps planning but is not required, and lesions are treated at the same time.

  • Treatment ladder: NSAIDs + hormonal contraceptives → GnRH analogues, aromatase inhibitors or danazol, or laparoscopic excision/ablation → if severe and family complete, hysterectomy ± bilateral salpingo-oophorectomy.

Traps the Examiner Sets

  • PCOS needs only 2 of 3 criteria — polycystic ovaries are not mandatory.

  • Hirsutism with virilisation = look for a tumour or adrenal cause, not PCOS.

  • Endometriosis pain does not correlate with the extent of disease.

  • Antiandrogens need contraception (fetal risk).

Memory Hooks & Shortcuts

Shortcuts to lock in this article's numbers and lists. Each one only re-packages facts proven above.

  • 🧠 Rotterdam: 'any 2 of A-H-P' — Anovulation, Hyperandrogenism, Polycystic ovaries — criteria

  • 🧠 PCO on scan '12 follicles, 2–9 mm, 10 ml' — ultrasound

  • 🧠 Tumour flags '150 and 800': testosterone >150, DHEAS >800 — tumour

  • 🧠 Endometriosis '3 Ds': Dysmenorrhoea, Dyspareunia, Difficulty conceiving — triad

  • 🧠 'Little disease, lots of pain' — endometriosis stage ≠ symptoms — staging

Rapid-Revision Cards

  • New name

    PMOS (formerly PCOS).

  • Prevalence

    5–10%.

  • Rotterdam

    2 of 3.

  • PCO on TVS

    ≥12 follicles 2–9 mm; >10 ml.

  • Adolescents

    No TVS.

  • Exclude

    hCG, FSH, PRL, TSH, 17-OHP, cortisol.

  • Tumour clues

    T >150 ng/dl; DHEAS >800.

  • Virilisation

    Not PCOS — tumour/adrenal.

  • Acanthosis

    Insulin resistance.

  • Endometrial risk

    Unopposed oestrogen.

  • Metabolic

    T2DM, IGT, OSA.

  • First step

    Weight loss.

  • Cycles

    COC/progestin.

  • Ovulation

    Letrozole or clomiphene.

  • Hirsutism #1

    PMOS.

  • Antiandrogens

    With contraception.

  • Endometriosis sites

    Ovary, cul-de-sac, uterosacrals.

  • Theory

    Retrograde menstruation.

  • Triad

    Dysmenorrhoea, dyspareunia, infertility.

  • Stage vs pain

    Not related.

  • Ladder

    NSAID+OCP → GnRH/AI/danazol → surgery.

Sources

Facts in this article were checked against these documents.

  • MSD Manual Professional: Polyendocrine Metabolic Ovarian Syndrome (PMOS); Endometriosis; Ovulatory Dysfunction; Hirsutism and Hypertrichosis — Merck & Co. (MSD Manuals), 2024–26 (link)

  • Competency Based Undergraduate Curriculum, Vol III: Obstetrics & Gynaecology (OG30) — National Medical Commission, 2024

Test Yourself: Practice Questions

Thirty questions in NEET PG style, most of them clinical vignettes.

Practice Questions (NEET PG pattern)

Original questions written in the style of the exam: +4 for a correct answer, −1 for a wrong one. Every answer was checked against the sources listed above. NEET PG papers are not published by NBEMS, so these are not past-paper questions.

Q1. MSD now uses which name for polycystic ovary syndrome?

  • (a) Stein–Leventhal disease only

  • (b) primary ovarian insufficiency

  • (c) ovarian hyperstimulation syndrome

  • (d) polyendocrine metabolic ovarian syndrome (PMOS)

Show answer

Answer: (d) — Same condition.


Q2. PMOS/PCOS affects about

  • (a) 70%

  • (b) 0.1%

  • (c) 40%

  • (d) 5–10% of women

Show answer

Answer: (d) — MSD.


Q3. The Rotterdam criteria need

  • (a) all 3 features

  • (b) polycystic ovaries plus obesity

  • (c) any 2 of: anovulation, hyperandrogenism, polycystic ovaries

  • (d) raised LH:FSH ratio

Show answer

Answer: (c) — PCO not mandatory.


Q4. On ultrasound, polycystic ovarian morphology is

  • (a) a single 5 cm cyst

  • (b) a dermoid

  • (c) ≥12 follicles of 2–9 mm per ovary and/or volume >10 ml

  • (d) ≥5 follicles of 20 mm

Show answer

Answer: (c) — MSD.


Q5. A 15-year-old with irregular periods and acne is suspected of PCOS. Which test is avoided at this age per MSD?

  • (a) prolactin

  • (b) transvaginal ultrasound

  • (c) serum testosterone

  • (d) TSH

Show answer

Answer: (b) — Not in adolescents.


Q6. To exclude non-classic congenital adrenal hyperplasia in a hirsute woman, measure

  • (a) AMH

  • (b) estradiol

  • (c) CA-125

  • (d) early-morning 17-hydroxyprogesterone

Show answer

Answer: (d) — MSD.


Q7. A woman with hirsutism has testosterone of 220 ng/dl. Suspect

  • (a) an androgen-secreting tumour

  • (b) simple PCOS

  • (c) normal variation

  • (d) hypothyroidism

Show answer

Answer: (a) — >150 ng/dl.


Q8. Markedly raised DHEAS (>800 mcg/dl) suggests

  • (a) pregnancy

  • (b) ovarian PCOS

  • (c) an adrenal androgen-secreting tumour

  • (d) Cushing's disease only

Show answer

Answer: (c) — MSD.


Q9. A hirsute woman develops clitoromegaly and a deep voice over 6 months. This virilisation suggests

  • (a) an androgen-secreting tumour or adrenal cause

  • (b) constitutional hirsutism

  • (c) drug-free normal

  • (d) uncomplicated PCOS

Show answer

Answer: (a) — Investigate urgently.


Q10. Before diagnosing PCOS, which tests exclude mimics?

  • (a) CA-125 only

  • (b) HbA1c only

  • (c) karyotype

  • (d) pregnancy test, FSH, prolactin, TSH (± cortisol)

Show answer

Answer: (d) — MSD.


Q11. Velvety dark skin on the neck in a woman with PCOS reflects

  • (a) insulin resistance (acanthosis nigricans)

  • (b) vitiligo

  • (c) high oestrogen

  • (d) Addison disease

Show answer

Answer: (a) — MSD.


Q12. Why is endometrial cancer risk raised in chronic anovulatory PCOS?

  • (a) high FSH

  • (b) unopposed oestrogen without cyclical progesterone

  • (c) high progesterone

  • (d) low oestrogen

Show answer

Answer: (b) — Protect with progestin.


Q13. A metabolic complication more common in PCOS is

  • (a) hyperthyroidism

  • (b) osteoporosis in youth

  • (c) hypocalcaemia

  • (d) type 2 diabetes and impaired glucose tolerance

Show answer

Answer: (d) — Also sleep apnoea.


Q14. First step for an obese woman with PCOS and irregular cycles:

  • (a) immediate IVF

  • (b) danazol

  • (c) hysterectomy

  • (d) weight loss and regular exercise

Show answer

Answer: (d) — May restore ovulation.


Q15. For cycle control and endometrial protection in PCOS (no pregnancy wish), use

  • (a) combined oral contraceptives or progestins

  • (b) GnRH agonists long-term

  • (c) oestrogen alone

  • (d) clomiphene

Show answer

Answer: (a) — MSD.


Q16. Antiandrogenic progestins used in PCOS include

  • (a) drospirenone and dienogest

  • (b) medroxyprogesterone only

  • (c) danazol

  • (d) levonorgestrel and norgestrel

Show answer

Answer: (a) — MSD.


Q17. An obese woman with PCOS wants to conceive. MSD says many clinicians prefer

  • (a) letrozole

  • (b) spironolactone

  • (c) danazol

  • (d) combined pills

Show answer

Answer: (a) — Clomiphene also first-line in PMOS chapter.


Q18. MSD's PMOS chapter names the first-line infertility drug as

  • (a) IVF

  • (b) clomiphene (letrozole also used)

  • (c) gonadotropins

  • (d) metformin alone

Show answer

Answer: (b) — Know both views.


Q19. The commonest cause of hirsutism is

  • (a) PMOS (PCOS)

  • (b) ovarian Sertoli–Leydig tumour

  • (c) Cushing syndrome

  • (d) adrenal carcinoma

Show answer

Answer: (a) — MSD.


Q20. Spironolactone for hirsutism in a sexually active woman must be combined with

  • (a) oestrogen alone

  • (b) reliable contraception

  • (c) metformin

  • (d) nothing

Show answer

Answer: (b) — Fetal risk.


Q21. Common sites of endometriosis include

  • (a) ovaries, posterior cul-de-sac and uterosacral ligaments

  • (b) liver and spleen

  • (c) kidneys only

  • (d) brain

Show answer

Answer: (a) — MSD.


Q22. The most widely accepted theory of endometriosis is

  • (a) infection

  • (b) trauma

  • (c) retrograde menstruation

  • (d) coelomic metaplasia only

Show answer

Answer: (c) — Also metaplasia, rests.


Q23. The classic triad of endometriosis is

  • (a) fever, pain, discharge

  • (b) hirsutism, acne, obesity

  • (c) amenorrhoea, galactorrhoea, headache

  • (d) dysmenorrhoea, dyspareunia, infertility

Show answer

Answer: (d) — ± dyschezia.


Q24. A woman with minimal endometriosis at laparoscopy has severe pain. This is

  • (a) expected — severity does not match stage

  • (b) a sign of cancer

  • (c) proof of another cause

  • (d) impossible

Show answer

Answer: (a) — MSD.


Q25. Endometriomas can impair fertility by

  • (a) raising sperm count

  • (b) blocking the cervix

  • (c) destroying primordial follicles (reduced reserve)

  • (d) causing hyperprolactinaemia

Show answer

Answer: (c) — Also adhesions.


Q26. A painful nodule in a caesarean scar may be

  • (a) scar endometriosis

  • (b) hernia only

  • (c) keloid

  • (d) lipoma

Show answer

Answer: (a) — MSD.


Q27. Is laparoscopy mandatory before treating suspected endometriosis?

  • (a) No — treatment can start on clinical diagnosis

  • (b) Only CA-125 is needed

  • (c) Yes, always

  • (d) Only CT is needed

Show answer

Answer: (a) — Helps planning.


Q28. First-line medical treatment of suspected endometriosis is

  • (a) NSAIDs plus hormonal contraceptives

  • (b) antibiotics

  • (c) hysterectomy

  • (d) danazol first

Show answer

Answer: (a) — Then GnRH analogues.


Q29. If first-line therapy fails, second-line options for endometriosis include

  • (a) metformin

  • (b) GnRH analogues, aromatase inhibitors or danazol

  • (c) oestrogen alone

  • (d) clomiphene

Show answer

Answer: (b) — Or laparoscopy.


Q30. A 46-year-old with severe endometriosis who has completed her family and failed treatment may be offered

  • (a) IVF

  • (b) observation only

  • (c) clomiphene

  • (d) hysterectomy with or without bilateral salpingo-oophorectomy

Show answer

Answer: (d) — MSD.

Active Recall

From memory: state the Rotterdam criteria and ultrasound definition, list tests to exclude mimics and tumour clues, describe PMOS long-term risks and treatment including ovulation induction, outline hirsutism management, and summarise endometriosis sites, theory, triad, diagnosis and treatment.